프레스티지바이오파마
5,050KRWMarket close of 10/27 (Tue)
Down -0.20%-10KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)4,220KRWDown -16.44%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 5,070
- High
- 5,160
- Low
- 4,940
- Day range
- Day range low 4,940 high 5,160, open 5,070, close 5,050, previous close 5,060
- Volume
- 7×10K shares
- 361.54 million KRW 2.11× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
0%0% of the way up from the lowest close in 1 year (252 sessions) · -63.3% from the high
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-48.03 million KRWOperating income over the last four quarters -48.03 million KRW (loss)
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 2 are within the usual range
- Daily move-0.20%usual range
- Trading value2.1×usual range
See the full check report
Quarterly results · Q4 2025
- Operating income-6.38 million KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
This quarter is derived: annual results minus Q1–Q3.
Quarterly operating income trend
As of the latest official close · 2026-10-27Valuation filing date · 2026-03-03Same sector · 바이오 R&D
Down -0.67%· 26 of 64 stocks up, preferred shares excluded · trading value 190.2B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -12.6% | Flat 0.00% | 51.8B KRW |
| 올릭스 | Close over the last 20 sessions -11.8% | Down -5.72% | 24.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -8.3% | Up +0.37% | 14.0B KRW |
| 리가켐바이오 | Close over the last 20 sessions -20.9% | Down -1.54% | 12.1B KRW |
| 페니트리움바이오 | Close over the last 20 sessions -4.2% | Up +14.41% | 9.8B KRW |
Schedule
- Next data 10/29 (Thu) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.